ImmunityBio, Inc. IBRX
8.44
(0.20)
(2.31%)
as of 25 Sep
- Market cap
- $9.2B
- P/E
- 0.0×
Follow IBRX
Growth Flags
show if company had growth for consecutive years
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
11,011.27 | 7,843.51 | 1,953.05 | 630.50 | 8,307.96 | 2,533.77 | 7,948.01 | 4,284.97 | 121.07 | 16.08 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(45.06) | (25.88) | (6.54) | (13.14) | (87.26) | (33.03) | (21.02) | (23.12) | (20.97) | (25.88) |
P/B ratio |
1.65 | 1.61 | 0.63 | 11.50 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
1.68 | 1.63 | 0.63 | 11.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
6,536.36 | 5,365.04 | 818.49 | 613.79 | 8,581.04 | 2,845.85 | 10,306.30 | 4,963.20 | 142.69 | 18.20 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(7.45) | (4.95) | (0.61) | (8.89) | (30.23) | (9.69) | (7.33) | (8.42) | (5.38) | (6.76) |
EV/FCF |
(6.37) | (2.89) | (0.51) | (8.65) | (29.94) | (9.23) | (5.66) | (7.77) | (5.28) | (6.68) |
Quick Ratio |
16.06 | 6.20 | 3.17 | 4.49 | 1.42 | 0.86 | 0.22 | 4.57 | 2.77 | 4.62 |
Current Ratio |
16.34 | 6.35 | 3.26 | 4.82 | 1.64 | 0.91 | 0.28 | 5.05 | 3.36 | 5.10 |
Net Debt/EBITDA |
1.65 | 1.37 | 0.76 | 0.26 | (0.80) | (0.92) | (1.79) | (1.38) | (1.03) | (0.97) |
Debt/Assets |
0.81% | 0.94% | 3.80% | 10.37% | 118.02% | 129.79% | 185.78% | 135.10% | 120.62% | 95.06% |
Debt/Equity |
0.01 | 0.01 | 0.05 | 0.12 | (2.20) | (2.50) | (1.50) | (1.16) | (0.95) | (0.95) |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.26 |
Operating CF/Net income |
0.32 | 0.51 | 0.66 | 0.96 | 0.77 | 0.79 | 0.81 | 0.63 | 0.95 | 0.87 |
Capex/Depreciation |
(1.13) | (4.86) | (1.27) | (0.29) | (0.12) | (0.89) | (2.77) | (0.49) | (0.17) | (0.25) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (37.21%) | (37.65%) | (52.75%) | (118.32%) | (20,269.62%) | 191.38% | 120.09% | 112.61% | 77.01% | 71.15% | |
| (35.31%) | (33.96%) | (44.51%) | (97.07%) | (121.73%) | (100.48%) | (100.22%) | (134.56%) | (93.21%) | (79.43%) | |
ROIC |
(80.17%) | (66.58%) | (78.07%) | (116.43%) | (295.46%) | (433.97%) | (189.00%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(57.12%) | (51.20%) | (69.53%) | (150.70%) | (191.05%) | (719.26%) | 192.30% | (152.72%) | (155.05%) | (95.65%) |
Average Days of Receivables |
22,132.27 | 10,203.78 | 94,496.17 | 50.22 | 312.51 | 520.93 | 2,874.38 | 0.00 | 58.42 | 137.16 |
Research and Development Expense of Revenue |
66,256.82% | 93,431.11% | 118,548.94% | 5,086.15% | 23,059.01% | 20,980.51% | 103,395.42% | 37,357.88% | 1,289.55% | 192.92% |
Selling, General and Administrative Expense of Revenue |
216,797.73% | 126,935.56% | 90,889.36% | 2,109.72% | 11,788.10% | 14,481.37% | 42,795.00% | 20,839.23% | 1,144.68% | 132.41% |
Intangible Assets out of Total Assets |
0.02 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.06 | 0.03 | 0.04 | 0.03 |
Share Based Compensation of Revenue |
167,845.45% | 82,215.56% | 49,748.94% | 155.36% | 361.49% | 6,122.16% | 16,741.25% | 7,904.02% | 233.52% | 32.49% |
Graham Net Nets |
0.37 | 0.29 | 0.58 | 0.02 | (0.05) | (0.16) | (0.35) | (0.30) | (0.38) | (0.38) |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 2.05 | 3.56 | 5.15 | 5.48 | 3.07 | 2.15 |
Earnings Yield |
(24.87%) | (27.40%) | (105.22%) | (18.73%) | (4.46%) | (14.75%) | (21.95%) | (22.14%) | (23.44%) | (19.19%) |
Free Cash Flow Yield |
(9.32%) | (23.68%) | (82.87%) | (11.25%) | (3.45%) | (12.17%) | (22.90%) | (14.91%) | (22.30%) | (16.95%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.12 |
Operating CF per Share |
(0.47) | (0.61) | (0.80) | (0.42) | (0.46) | (0.70) | (0.84) | (0.72) | (0.56) | (0.33) |
Capex per Share |
(0.08) | (0.43) | (0.16) | (0.01) | 0.00 | (0.03) | (0.25) | (0.06) | (0.01) | 0.00 |
Free Cash Flow per Share |
(0.55) | (1.04) | (0.96) | (0.43) | (0.46) | (0.74) | (1.09) | (0.78) | (0.57) | (0.34) |
Cash per Share |
2.43 | 1.59 | 0.94 | 0.14 | 0.25 | 0.81 | 0.27 | 0.52 | 0.21 | 0.26 |
Shareholders Equity per Share |
3.58 | 2.72 | 1.85 | 0.33 | (0.31) | (0.63) | (1.12) | (1.15) | (0.70) | (0.54) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
3.58 | 2.72 | 1.85 | 0.33 | (0.31) | (0.63) | (1.12) | (1.15) | (0.70) | (0.54) |
Free Cash Flow |
(45.15) | (83.59) | (76.07) | (156.20) | (173.39) | (287.48) | (436.90) | (397.34) | (398.12) | (308.78) |
Working Capital |
192.59 | 111.59 | 61.51 | 44.20 | 43.58 | (34.65) | (360.28) | 235.80 | 129.64 | 253.12 |
Capital Expenditures |
(6.56) | (34.81) | (12.69) | (4.09) | (1.67) | (13.06) | (99.39) | (30.58) | (6.89) | (3.85) |
Net Current Asset Value |
181.07 | 100.86 | 52.83 | 33.31 | (228.16) | (378.48) | (671.60) | (796.30) | (686.48) | (686.60) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
149.09 | 773.67 | 270.00 | 1.86 | 2.76 | 13.99 | 414.13 | 49.17 | 0.47 | 0.03 |
Net Profit Margin |
(274,565.91%) | (214,273.33%) | (204,736.17%) | (7,165.17%) | (36,669.59%) | (37,129.55%) | (173,569.58%) | (93,761.41%) | (2,804.77%) | (310.18%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.31 | 0.09 | 0.13 | 0.23 | 0.19 | 0.18 | 0.25 | 0.42 | 0.29 | 0.14 |
Cash ROIC |
(11.62%) | (35.93%) | (61.77%) | (113.59%) | (102.27%) | (52.40%) | (145.57%) | (141.64%) | (427.60%) | (190.25%) |
Accounts Receivable Turnover |
0.03 | 0.02 | 0.01 | 0.35 | 1.47 | 1.01 | 0.15 | 0.00 | 6.94 | 5.04 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.49 | 0.00 | 0.00 | 0.11 |
Inventory Turnover |
— | — | — | — | — | — | 0.00 | — | — | 0.16 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 317.08 | 0.00 | 0.00 | 3,382.43 |
Days of Inventory on Hand |
— | — | — | — | — | — | 0.00 | — | 0.00 | 441.10 |
Average Receivables |
1.47 | 1.96 | 6.71 | 6.24 | 0.41 | 0.93 | 1.61 | — | 2.13 | 22.47 |
Average Payables |
3.07 | 4.96 | 4.33 | 2.27 | 6.63 | 11.46 | 16.22 | 15.11 | 7.96 | 6.85 |
Average Inventory |
— | — | — | — | — | — | — | — | — | 4.59 |
Average Assets |
342.17 | 283.97 | 216.20 | 162.54 | 182.25 | 345.15 | 415.63 | 433.40 | 443.69 | 442.42 |
Average Common Equity |
324.71 | 256.13 | 182.43 | 133.34 | 1.09 | (181.20) | (346.87) | (517.88) | (537.03) | (493.85) |
Columns are period end dates